Maneesh Jain leads Mirvie’s efforts to develop the first test to predict pregnancy complications by revealing the underlying biology of pregnancy health. As a proven life-science entrepreneur, Maneesh has served in founding, executive and board roles at transformational biotech startups addressing large unmet needs for over two decades. He has helped pioneer the first platforms to create more accessible next generation sequencing (Ion Torrent) and medical ultrasound imaging (Butterfly Network), as well as the first liquid biopsy plasma test for the early detection of cancer (Cirina and Grail). In his current role at Mirvie, Maneesh oversees the development of the Mirvie RNA platform, which combines revolutionary analysis of tens of thousands of RNA messages from the baby, the placenta and the mom with machine learning to predict unexpected complications before they happen and enable proactive, preventive, and personalized pregnancy care. Maneesh also serves as an independent board member for Mission Bio and Mammoth Biosciences and Adela, holds degrees from Caltech and Stanford, and is an author on over 20 publications and 10 patents.